UniProt ID | RD23A_HUMAN | |
---|---|---|
UniProt AC | P54725 | |
Protein Name | UV excision repair protein RAD23 homolog A | |
Gene Name | RAD23A | |
Organism | Homo sapiens (Human). | |
Sequence Length | 363 | |
Subcellular Localization | Nucleus. | |
Protein Description | Multiubiquitin chain receptor involved in modulation of proteasomal degradation. Binds to 'Lys-48'-linked polyubiquitin chains in a length-dependent manner and with a lower affinity to 'Lys-63'-linked polyubiquitin chains. Proposed to be capable to bind simultaneously to the 26S proteasome and to polyubiquitinated substrates and to deliver ubiquitinated proteins to the proteasome.; Involved in nucleotide excision repair and is thought to be functional equivalent for RAD23B in global genome nucleotide excision repair (GG-NER) by association with XPC. In vitro, the XPC:RAD23A dimer has NER activity. Can stabilize XPC.; Involved in vpr-dependent replication of HIV-1 in non-proliferating cells and primary macrophages. Required for the association of HIV-1 vpr with the host proteasome.. | |
Protein Sequence | MAVTITLKTLQQQTFKIRMEPDETVKVLKEKIEAEKGRDAFPVAGQKLIYAGKILSDDVPIRDYRIDEKNFVVVMVTKTKAGQGTSAPPEASPTAAPESSTSFPPAPTSGMSHPPPAAREDKSPSEESAPTTSPESVSGSVPSSGSSGREEDAASTLVTGSEYETMLTEIMSMGYERERVVAALRASYNNPHRAVEYLLTGIPGSPEPEHGSVQESQVSEQPATEAAGENPLEFLRDQPQFQNMRQVIQQNPALLPALLQQLGQENPQLLQQISRHQEQFIQMLNEPPGELADISDVEGEVGAIGEEAPQMNYIQVTPQEKEAIERLKALGFPESLVIQAYFACEKNENLAANFLLSQNFDDE | |
Overview of Protein Modification Sites with Functional and Structural Information | ||
* ASA = Accessible Surface Area
Locations | Modification | Substrate Peptides & Secondary Structure |
ASA (%) | Reference | Orthologous Protein Cluster |
---|---|---|---|---|---|
8 | Ubiquitination | MAVTITLKTLQQQTF CCEEEEECHHHHCEE | 38.24 | 21890473 | |
8 | Ubiquitination | MAVTITLKTLQQQTF CCEEEEECHHHHCEE | 38.24 | 21890473 | |
8 | Ubiquitination | MAVTITLKTLQQQTF CCEEEEECHHHHCEE | 38.24 | 21890473 | |
16 | Ubiquitination | TLQQQTFKIRMEPDE HHHHCEEEEECCCCH | 32.56 | 21890473 | |
16 | Acetylation | TLQQQTFKIRMEPDE HHHHCEEEEECCCCH | 32.56 | 25953088 | |
16 | Ubiquitination | TLQQQTFKIRMEPDE HHHHCEEEEECCCCH | 32.56 | 21906983 | |
16 | Ubiquitination | TLQQQTFKIRMEPDE HHHHCEEEEECCCCH | 32.56 | 21890473 | |
19 | Sulfoxidation | QQTFKIRMEPDETVK HCEEEEECCCCHHHH | 11.32 | 21406390 | |
26 | Ubiquitination | MEPDETVKVLKEKIE CCCCHHHHHHHHHHH | 49.63 | 21890473 | |
26 | Ubiquitination | MEPDETVKVLKEKIE CCCCHHHHHHHHHHH | 49.63 | 21890473 | |
26 | Ubiquitination | MEPDETVKVLKEKIE CCCCHHHHHHHHHHH | 49.63 | 21906983 | |
29 | Ubiquitination | DETVKVLKEKIEAEK CHHHHHHHHHHHHHC | 61.01 | - | |
31 | Ubiquitination | TVKVLKEKIEAEKGR HHHHHHHHHHHHCCC | 44.23 | - | |
33 | Ubiquitination | KVLKEKIEAEKGRDA HHHHHHHHHHCCCCC | 62.94 | - | |
36 | Ubiquitination | KEKIEAEKGRDAFPV HHHHHHHCCCCCCCC | 67.31 | - | |
47 | Malonylation | AFPVAGQKLIYAGKI CCCCCCCEEEECCEE | 35.61 | 26320211 | |
47 | Ubiquitination | AFPVAGQKLIYAGKI CCCCCCCEEEECCEE | 35.61 | 21890473 | |
47 | Ubiquitination | AFPVAGQKLIYAGKI CCCCCCCEEEECCEE | 35.61 | 21890473 | |
47 | Acetylation | AFPVAGQKLIYAGKI CCCCCCCEEEECCEE | 35.61 | 23954790 | |
47 | Ubiquitination | AFPVAGQKLIYAGKI CCCCCCCEEEECCEE | 35.61 | 21890473 | |
53 | Ubiquitination | QKLIYAGKILSDDVP CEEEECCEECCCCCC | 32.10 | 21890473 | |
53 | Ubiquitination | QKLIYAGKILSDDVP CEEEECCEECCCCCC | 32.10 | 21890473 | |
53 | Ubiquitination | QKLIYAGKILSDDVP CEEEECCEECCCCCC | 32.10 | 21890473 | |
53 | Acetylation | QKLIYAGKILSDDVP CEEEECCEECCCCCC | 32.10 | 23954790 | |
56 | Phosphorylation | IYAGKILSDDVPIRD EECCEECCCCCCCCC | 34.93 | - | |
64 | Ubiquitination | DDVPIRDYRIDEKNF CCCCCCCEEECCCCE | 10.30 | - | |
69 | Ubiquitination | RDYRIDEKNFVVVMV CCEEECCCCEEEEEE | 52.52 | 21890473 | |
69 | Ubiquitination | RDYRIDEKNFVVVMV CCEEECCCCEEEEEE | 52.52 | 21906983 | |
69 | Ubiquitination | RDYRIDEKNFVVVMV CCEEECCCCEEEEEE | 52.52 | 21890473 | |
70 | Ubiquitination | DYRIDEKNFVVVMVT CEEECCCCEEEEEEE | 32.66 | - | |
78 | Ubiquitination | FVVVMVTKTKAGQGT EEEEEEEECCCCCCC | 36.30 | 21906983 | |
80 | Ubiquitination | VVMVTKTKAGQGTSA EEEEEECCCCCCCCC | 52.67 | 20972266 | |
85 | Phosphorylation | KTKAGQGTSAPPEAS ECCCCCCCCCCCCCC | 17.52 | 29496963 | |
86 | Phosphorylation | TKAGQGTSAPPEASP CCCCCCCCCCCCCCC | 45.67 | 25850435 | |
86 | Ubiquitination | TKAGQGTSAPPEASP CCCCCCCCCCCCCCC | 45.67 | - | |
92 | Phosphorylation | TSAPPEASPTAAPES CCCCCCCCCCCCCCC | 22.56 | 25159151 | |
94 | Phosphorylation | APPEASPTAAPESST CCCCCCCCCCCCCCC | 32.72 | 25159151 | |
99 | Phosphorylation | SPTAAPESSTSFPPA CCCCCCCCCCCCCCC | 37.55 | 29116813 | |
100 | Phosphorylation | PTAAPESSTSFPPAP CCCCCCCCCCCCCCC | 26.80 | 25159151 | |
101 | Phosphorylation | TAAPESSTSFPPAPT CCCCCCCCCCCCCCC | 43.60 | 28464451 | |
102 | Phosphorylation | AAPESSTSFPPAPTS CCCCCCCCCCCCCCC | 37.39 | 28464451 | |
108 | O-linked_Glycosylation | TSFPPAPTSGMSHPP CCCCCCCCCCCCCCC | 39.76 | OGP | |
108 | Phosphorylation | TSFPPAPTSGMSHPP CCCCCCCCCCCCCCC | 39.76 | 25850435 | |
109 | Phosphorylation | SFPPAPTSGMSHPPP CCCCCCCCCCCCCCC | 31.29 | 28122231 | |
112 | Phosphorylation | PAPTSGMSHPPPAAR CCCCCCCCCCCCCCC | 36.05 | 26074081 | |
122 | Ubiquitination | PPAAREDKSPSEESA CCCCCCCCCCCCCCC | 60.56 | 18781797 | |
122 | Acetylation | PPAAREDKSPSEESA CCCCCCCCCCCCCCC | 60.56 | 26051181 | |
123 | Phosphorylation | PAAREDKSPSEESAP CCCCCCCCCCCCCCC | 46.08 | 29255136 | |
125 | Phosphorylation | AREDKSPSEESAPTT CCCCCCCCCCCCCCC | 62.17 | 29255136 | |
128 | Phosphorylation | DKSPSEESAPTTSPE CCCCCCCCCCCCCCC | 35.18 | 29255136 | |
131 | Phosphorylation | PSEESAPTTSPESVS CCCCCCCCCCCCCCC | 39.35 | 30266825 | |
132 | Phosphorylation | SEESAPTTSPESVSG CCCCCCCCCCCCCCC | 41.02 | 29255136 | |
133 | Phosphorylation | EESAPTTSPESVSGS CCCCCCCCCCCCCCC | 29.19 | 23927012 | |
136 | Phosphorylation | APTTSPESVSGSVPS CCCCCCCCCCCCCCC | 25.60 | 23927012 | |
138 | Phosphorylation | TTSPESVSGSVPSSG CCCCCCCCCCCCCCC | 34.33 | 23927012 | |
140 | Phosphorylation | SPESVSGSVPSSGSS CCCCCCCCCCCCCCC | 24.29 | 23927012 | |
143 | Phosphorylation | SVSGSVPSSGSSGRE CCCCCCCCCCCCCCC | 45.21 | 23927012 | |
144 | Phosphorylation | VSGSVPSSGSSGREE CCCCCCCCCCCCCCC | 36.30 | 23927012 | |
146 | Phosphorylation | GSVPSSGSSGREEDA CCCCCCCCCCCCCHH | 31.41 | 23927012 | |
147 | Phosphorylation | SVPSSGSSGREEDAA CCCCCCCCCCCCHHH | 45.45 | 23927012 | |
155 | Phosphorylation | GREEDAASTLVTGSE CCCCHHHHHCCCCHH | 24.80 | 27251275 | |
156 | Phosphorylation | REEDAASTLVTGSEY CCCHHHHHCCCCHHH | 22.11 | 27251275 | |
159 | Phosphorylation | DAASTLVTGSEYETM HHHHHCCCCHHHHHH | 37.80 | 26552605 | |
161 | Phosphorylation | ASTLVTGSEYETMLT HHHCCCCHHHHHHHH | 27.86 | 26552605 | |
163 | Phosphorylation | TLVTGSEYETMLTEI HCCCCHHHHHHHHHH | 20.56 | 20068231 | |
165 | Phosphorylation | VTGSEYETMLTEIMS CCCHHHHHHHHHHHH | 19.31 | 20068231 | |
166 | Sulfoxidation | TGSEYETMLTEIMSM CCHHHHHHHHHHHHC | 2.66 | 30846556 | |
168 | O-linked_Glycosylation | SEYETMLTEIMSMGY HHHHHHHHHHHHCCC | 16.79 | OGP | |
168 | Phosphorylation | SEYETMLTEIMSMGY HHHHHHHHHHHHCCC | 16.79 | 23663014 | |
171 | Sulfoxidation | ETMLTEIMSMGYERE HHHHHHHHHCCCCHH | 1.51 | 30846556 | |
172 | Phosphorylation | TMLTEIMSMGYERER HHHHHHHHCCCCHHH | 18.08 | 23663014 | |
173 | Sulfoxidation | MLTEIMSMGYERERV HHHHHHHCCCCHHHH | 3.52 | 30846556 | |
175 | Phosphorylation | TEIMSMGYERERVVA HHHHHCCCCHHHHHH | 11.81 | 23663014 | |
188 | Phosphorylation | VAALRASYNNPHRAV HHHHHHHCCCHHHHH | 20.27 | 28857561 | |
197 | Phosphorylation | NPHRAVEYLLTGIPG CHHHHHHHHHHCCCC | 10.62 | 28176443 | |
197 (in isoform 3) | Phosphorylation | - | 10.62 | 28176443 | |
200 | Phosphorylation | RAVEYLLTGIPGSPE HHHHHHHHCCCCCCC | 30.39 | 28176443 | |
200 (in isoform 3) | Phosphorylation | - | 30.39 | 30108239 | |
205 (in isoform 3) | Phosphorylation | - | 22.27 | 30108239 | |
205 | Phosphorylation | LLTGIPGSPEPEHGS HHHCCCCCCCCCCCC | 22.27 | 28176443 | |
212 (in isoform 3) | Phosphorylation | - | 23.64 | 30108239 | |
212 | Phosphorylation | SPEPEHGSVQESQVS CCCCCCCCCCHHHCC | 23.64 | 28176443 | |
216 (in isoform 3) | Phosphorylation | - | 20.84 | 30108239 | |
216 | Phosphorylation | EHGSVQESQVSEQPA CCCCCCHHHCCCCCC | 20.84 | 28176443 | |
219 | Phosphorylation | SVQESQVSEQPATEA CCCHHHCCCCCCCHH | 23.91 | 28176443 | |
219 (in isoform 3) | Phosphorylation | - | 23.91 | 30108239 | |
224 | O-linked_Glycosylation | QVSEQPATEAAGENP HCCCCCCCHHCCCCH | 32.61 | OGP | |
224 (in isoform 3) | Phosphorylation | - | 32.61 | 30108239 | |
224 | Phosphorylation | QVSEQPATEAAGENP HCCCCCCCHHCCCCH | 32.61 | 28176443 | |
244 | Sulfoxidation | DQPQFQNMRQVIQQN CCHHHHHHHHHHHHC | 1.89 | 21406390 | |
274 | Phosphorylation | PQLLQQISRHQEQFI HHHHHHHHHHHHHHH | 21.26 | 27251275 | |
295 | Phosphorylation | PGELADISDVEGEVG CCCCCCHHHCCCCCC | 35.83 | 28348404 | |
313 | Phosphorylation | EEAPQMNYIQVTPQE CCCCCCCEEEECHHH | 6.33 | 28464451 | |
317 | Phosphorylation | QMNYIQVTPQEKEAI CCCEEEECHHHHHHH | 11.68 | 20068231 | |
321 | Ubiquitination | IQVTPQEKEAIERLK EEECHHHHHHHHHHH | 47.39 | - | |
357 | Phosphorylation | LAANFLLSQNFDDE- HHHHHHHHCCCCCC- | 25.81 | 17525332 |
Modified Location | Modified Residue | Modification | Function | Reference | ||
---|---|---|---|---|---|---|
Oops, there are no descriptions of PTM sites of RD23A_HUMAN !! |
* Distance = the distance between SAP position and PTM sites.
Modified Location | Modification | Variant Position (Distance <= 10) |
Residue Change | SAP | Related Disease | Reference |
---|---|---|---|---|---|---|
Oops, there are no SNP-PTM records of RD23A_HUMAN !! |
Kegg Disease | ||||||
---|---|---|---|---|---|---|
There are no disease associations of PTM sites. | ||||||
OMIM Disease | ||||||
There are no disease associations of PTM sites. | ||||||
Kegg Drug | ||||||
There are no disease associations of PTM sites. | ||||||
DrugBank | ||||||
There are no disease associations of PTM sites. |
loading...
Phosphorylation | |
Reference | PubMed |
"A quantitative atlas of mitotic phosphorylation."; Dephoure N., Zhou C., Villen J., Beausoleil S.A., Bakalarski C.E.,Elledge S.J., Gygi S.P.; Proc. Natl. Acad. Sci. U.S.A. 105:10762-10767(2008). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-133; SER-205; SER-295AND SER-357, AND MASS SPECTROMETRY. | |
"ATM and ATR substrate analysis reveals extensive protein networksresponsive to DNA damage."; Matsuoka S., Ballif B.A., Smogorzewska A., McDonald E.R. III,Hurov K.E., Luo J., Bakalarski C.E., Zhao Z., Solimini N.,Lerenthal Y., Shiloh Y., Gygi S.P., Elledge S.J.; Science 316:1160-1166(2007). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-357, AND MASSSPECTROMETRY. | |
"Global proteomic profiling of phosphopeptides using electron transferdissociation tandem mass spectrometry."; Molina H., Horn D.M., Tang N., Mathivanan S., Pandey A.; Proc. Natl. Acad. Sci. U.S.A. 104:2199-2204(2007). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-123 AND SER-128, ANDMASS SPECTROMETRY. | |
"Quantitative phosphoproteome profiling of Wnt3a-mediated signalingnetwork: indicating the involvement of ribonucleoside-diphosphatereductase M2 subunit phosphorylation at residue serine 20 in canonicalWnt signal transduction."; Tang L.-Y., Deng N., Wang L.-S., Dai J., Wang Z.-L., Jiang X.-S.,Li S.-J., Li L., Sheng Q.-H., Wu D.-Q., Li L., Zeng R.; Mol. Cell. Proteomics 6:1952-1967(2007). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-205, AND MASSSPECTROMETRY. | |
Ubiquitylation | |
Reference | PubMed |
"Quantitative analysis of global ubiquitination in HeLa cells by massspectrometry."; Meierhofer D., Wang X., Huang L., Kaiser P.; J. Proteome Res. 7:4566-4576(2008). Cited for: UBIQUITINATION [LARGE SCALE ANALYSIS] AT LYS-122, AND MASSSPECTROMETRY. |